REPORT ID 4771

United States Human Papillomavirus Protein E6 Market Report 2017

Publish Date
19-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the United States Human Papillomavirus Protein E6 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Human Papillomavirus Protein E6 in these regions, from 2012 to 2022 (forecast).

United States Human Papillomavirus Protein E6 market competition by top manufacturers/players, with Human Papillomavirus Protein E6 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Rottapharm Biotech Srl
    Selecta Biosciences Inc
    Transgene SA
    Abion Inc
    BioNTech AG
    Cancer Research Technology Ltd
    Etubics Corp
    Genexine Inc
    Hookipa Biotech AG
    Inovio Pharmaceuticals Inc
    MedImmune LLC

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ABN-301
    BVAC-C
    ETBX-041
    GX-188E
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Cervical Intraepithelial Neoplasia
    Lung Cancer
    Oropharyngeal Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Human Papillomavirus Protein E6 Market Report 2017
1 Human Papillomavirus Protein E6 Overview
    1.1 Product Overview and Scope of Human Papillomavirus Protein E6
    1.2 Classification of Human Papillomavirus Protein E6 by Product Category
        1.2.1 United States Human Papillomavirus Protein E6 Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Human Papillomavirus Protein E6 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 ABN-301
        1.2.4 BVAC-C
        1.2.5 ETBX-041
        1.2.6 GX-188E
        1.2.7 Others
    1.3 United States Human Papillomavirus Protein E6 Market by Application/End Users
        1.3.1 United States Human Papillomavirus Protein E6 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Cervical Intraepithelial Neoplasia
        1.3.3 Lung Cancer
        1.3.4 Oropharyngeal Cancer
        1.3.5 Others
    1.4 United States Human Papillomavirus Protein E6 Market by Region
        1.4.1 United States Human Papillomavirus Protein E6 Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Human Papillomavirus Protein E6 Status and Prospect (2012-2022)
        1.4.3 Southwest Human Papillomavirus Protein E6 Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Human Papillomavirus Protein E6 Status and Prospect (2012-2022)
        1.4.5 New England Human Papillomavirus Protein E6 Status and Prospect (2012-2022)
        1.4.6 The South Human Papillomavirus Protein E6 Status and Prospect (2012-2022)
        1.4.7 The Midwest Human Papillomavirus Protein E6 Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Human Papillomavirus Protein E6 (2012-2022)
        1.5.1 United States Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2022)
        1.5.2 United States Human Papillomavirus Protein E6 Revenue and Growth Rate (2012-2022)

2 United States Human Papillomavirus Protein E6 Market Competition by Players/Suppliers
    2.1 United States Human Papillomavirus Protein E6 Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Human Papillomavirus Protein E6 Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Human Papillomavirus Protein E6 Average Price by Players/Suppliers (2012-2017)
    2.4 United States Human Papillomavirus Protein E6 Market Competitive Situation and Trends
        2.4.1 United States Human Papillomavirus Protein E6 Market Concentration Rate
        2.4.2 United States Human Papillomavirus Protein E6 Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Human Papillomavirus Protein E6 Manufacturing Base Distribution, Sales Area, Product Type

3 United States Human Papillomavirus Protein E6 Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Human Papillomavirus Protein E6 Sales and Market Share by Region (2012-2017)
    3.2 United States Human Papillomavirus Protein E6 Revenue and Market Share by Region (2012-2017)
    3.3 United States Human Papillomavirus Protein E6 Price by Region (2012-2017)

4 United States Human Papillomavirus Protein E6 Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Human Papillomavirus Protein E6 Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Human Papillomavirus Protein E6 Revenue and Market Share by Type (2012-2017)
    4.3 United States Human Papillomavirus Protein E6 Price by Type (2012-2017)
    4.4 United States Human Papillomavirus Protein E6 Sales Growth Rate by Type (2012-2017)

5 United States Human Papillomavirus Protein E6 Sales (Volume) by Application (2012-2017)
    5.1 United States Human Papillomavirus Protein E6 Sales and Market Share by Application (2012-2017)
    5.2 United States Human Papillomavirus Protein E6 Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Human Papillomavirus Protein E6 Players/Suppliers Profiles and Sales Data
    6.1 Rottapharm Biotech Srl
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Rottapharm Biotech Srl Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Selecta Biosciences Inc
        6.2.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Selecta Biosciences Inc Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Transgene SA
        6.3.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Transgene SA Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abion Inc
        6.4.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abion Inc Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 BioNTech AG
        6.5.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 BioNTech AG Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Cancer Research Technology Ltd
        6.6.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Cancer Research Technology Ltd Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Etubics Corp
        6.7.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Etubics Corp Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Genexine Inc
        6.8.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Genexine Inc Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Hookipa Biotech AG
        6.9.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Hookipa Biotech AG Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Inovio Pharmaceuticals Inc
        6.10.2 Human Papillomavirus Protein E6 Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 MedImmune LLC

7 Human Papillomavirus Protein E6 Manufacturing Cost Analysis
    7.1 Human Papillomavirus Protein E6 Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Human Papillomavirus Protein E6

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Human Papillomavirus Protein E6 Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Human Papillomavirus Protein E6 Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Human Papillomavirus Protein E6 Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Human Papillomavirus Protein E6 Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Human Papillomavirus Protein E6 Sales Volume Forecast by Type (2017-2022)
    11.3 United States Human Papillomavirus Protein E6 Sales Volume Forecast by Application (2017-2022)
    11.4 United States Human Papillomavirus Protein E6 Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer